The Obama-Biden administration facilitated the expansion of Chinese Communist Party-linked BGI Genomics into the U.S., forcing the Trump administration’s Departments of State and Homeland Security to block states from using the firm’s coronavirus test kits. From Beijing to the Beltway. The Obama administration allowed the Chinese firm to gain a foothold in the U.S. through its Committee on Foreign Investment in the U.S. (CFIUS), allowing BGI to acquire the California-based firm Complete Genomics. The 2012 deal was highly controversial, seen by many as a national security threat as it granted a Chinese company access to the genetic data of millions
